Opens in a new tab

GLOBAL REGULATORY PARTNERS JAPAN JOINS THE TOKYO CHAMBER OF COMMERCE AND INDUSTRY (TCCI)

Announcement, Press Release

Strengthening local connections as GRP Japan celebrates 10 years in Japan

Link to Document HERE

TOKYO, JAPAN
November 2026		MEMBERSHIP
TCCI / 東京商工会議所		LOCAL CHAPTER
Minato Branch / 港支部

Tokyo, Japan — November 2026 — Global Regulatory Partners Japan (GRP Japan) is pleased to announce that it has joined the Tokyo Chamber of Commerce and Industry (TCCI / 東京商工会議所), effective November 2026. GRP Japan will belong to the Minato Branch (港支部), one of TCCI’s 23 ward-based branches, strengthening the company’s connection with the local business community in Minato Ward.

The membership comes as GRP Japan celebrates its 10th anniversary in Japan, marking another step in the company’s continued commitment to building strong relationships within the Japanese business and healthcare communities.

Through its membership, GRP Japan looks forward to expanding its engagement with companies and organizations across Tokyo, participating in business and networking initiatives, and contributing its international life-sciences perspective to the broader business community.

“As GRP Japan celebrates ten years in Japan, joining the Tokyo Chamber of Commerce and Industry represents an important next step in strengthening our connection with the local business community. GRP has always seen itself as a bridge between global healthcare innovators and the Japanese market. We look forward to building new relationships through TCCI and contributing to the continued growth and international development of Tokyo’s business community.”
— Mariam Davis, Vice President, Global Regulatory Partners Japan

ORGANIZATION PROFILES

ABOUT TCCI Established in 1878, the Tokyo Chamber of Commerce and Industry (TCCI) represents approximately 89,000 member businesses and organizations across Tokyo. Through its 23 ward-based branches, TCCI supports the business community with management support, training, networking, business-matching opportunities, and other initiatives.ABOUT GRP JAPAN Established in Tokyo in 2016, Global Regulatory Partners Japan supports pharmaceutical, biotechnology, medical device, diagnostic, and other healthcare companies entering and operating in Japan. GRP Japan provides regulatory, MAH, quality, safety, medical information, importation, supply-chain, and lifecycle support as part of the Global Regulatory Partners Group.
2026 MARKS GRP JAPAN’S 10TH ANNIVERSARY  •  A DECADE OF PARTNERSHIP. A HEALTHIER TOMORROW.

MEDIA & COMPANY INFORMATION

Global Regulatory Partners Japan  |  globalregulatorypartners.com  |  globalregulatorypartners.co.jp

Related News

  • Global Regulatory Partners Announces MHLW Approval of Aflibercept Biosimilar Prefilled Syringe in Japan

    Tokyo, Japan - October 26, 2026 - Global Regulatory Partners GK (GRP) announced today that Japan's Ministry of Health, Labour and Welfare (MHLW) granted marketing approval on October 13, 2026 for Aflibercept BS Solution for Intravitreal Injection Kit 40 mg/mL [GRP] (prefilled syringe (PFS) presentation), a biosimilar to EYLEA®¹ (aflibercept), for ophthalmic use.
    View More

  • Baqsimi® Nasal Powder Featured in the September 2026 Issue of Nikkei DI

    Global Regulatory Partners GK (GRP Japan) is pleased to share that Baqsimi® Nasal Powder, for which GRP Japan serves as the Marketing Authorization Holder (MAH) in Japan, is featured in the September 2026 issue of Nikkei Drug Information (Nikkei DI). Nikkei DI is a professional publication for pharmacists and other healthcare professionals in Japan, providing information on pharmaceuticals, clinical practice, medication management and developments relevant to pharmacy practice.
    View More

  • GRP JAPAN JOINS THE JAPAN RADIOPHARMACEUTICALS ASSOCIATION

    Tokyo, Japan — October 2026 — Global Regulatory Partners Japan (GRP Japan) is pleased to announce that it has joined the Japan Radiopharmaceuticals Association, effective October 2026. The membership marks an important step in GRP Japan’s continued expansion into the radiopharmaceutical and nuclear medicine sector, complementing the company’s established capabilities in pharmaceuticals, biologics, medical devices, and diagnostics. As a Marketing Authorization Holder (MAH) and local regulatory partner for international healthcare companies entering Japan, GRP Japan is expanding its capabilities to support the specialized regulatory, quality, importation, supply-chain, and lifecycle requirements associated with radiopharmaceutical products. Through its membership, GRP Japan looks forward to industry collaboration and to contributing its regulatory and market-access experience to the continued development of the sector in Japan.
    View More

  • Global Regulatory Partners to Exhibit at BioJapan  2026

    Global Regulatory Partners (GRP) is pleased to announce its participation in BioJapan  2026, where GRP will exhibit at Booth C-41 and participate in the event's international Partnering program. BioJapan  2026 is observing its 40th anniversary as the world’s longest running biotechnology event.  It is held together with concurrent events,Regenerative Medicine JAPAN, and healthTECH JAPAN, bringing together biotechnology, pharmaceuticals, regenerative medicine, digital health, academia, investors, service providers, and other life-science stakeholders from Japan and around the world.
    View More